Diabetes complications

Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients

Diabetes MetabPublished Nationwide observational cohort study

Authors' conclusion

Although the crude prevalent burden of CV diseases may be lower in T1DM than in T2DM, patients with T1DM may have a higher risk of incident MI, HF, all-cause death and CV death above 60 years of age, highlighting the need for improved prevention in this population.

Study context

Population
All adult patients hospitalized in French hospitals in 2013 with at least 5 years of follow-up, categorized by diabetes status2,033,239 person-years
Participants
50,623 vs 425,207
Exposure
T1D vs T2D
  • T1DMn = 50,623
  • T2DMn = 425,207reference
Outcome
Prevalence and event rates of MI, HF, ischemic stroke, CKD, all-cause death and CV death
Follow-up
Median 5.3 years (IQR 2.8 - 5.8 years)
Methodological detailshospitalized patients, age stratification of 10-year intervals, age and sex-adjusted
  • Hospitalized patients
  • Age stratification of 10-year intervals
  • Age and sex-adjusted

Main finding

As reported in the abstract

Incident events, age and sex-adjusted HR, T1DM vs T2DM
-fold
HR, myocardial infarction (MI) (above 60 years) 1.2
-fold
HR, heart failure (HF) (above 60 years) 1.4
-fold higher in T1DM
Risk of incident chronic kidney disease (CKD) (above 60 years) 2.4
-fold higher in T1DM
HR, all-cause death (after 60 years) 1.1
-fold higher in T1DM
Cardiovascular (CV) death risk (60–69 years) 1.15

Observational data: associations, not effects.

Further findings

Age and sex-adjusted prevalence

Prevalence of CV diseases higher in T2DM for ages above 40 years
Prevalence of CKD more common in T1DM between ages 18 and 70 years

Original publication

Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients. Diabetes Metab. Published 1 February 2023. doi:10.1016/j.diabet.2023.101429

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.